Latest Twist In US Entresto Case Sees MSN Triumph Over Novartis
Appeal Filed And Generics Firm Remains Blocked From Launching
The latest twist in MSN’s legal fight with Novartis over Entresto has seen a US court rule that the FDA was correct to approve MSN’s skinny-label generic, which carves out certain protected Entresto indications. However, an appeal has already been filed and an imminent generic launch looks unlikely.
